GLP-1: Compound Profile

GLP-1 sits in the incretin arm of the metabolic peptide class, where the research question is receptor signaling rather than any downstream physiology. This profile covers what the name refers to, the receptor mechanism the literature attributes to it, and where it sits among the other peptides studied in the same area. For the wider grouping, the metabolic peptides overview is the class hub.

What is GLP-1?#

In a research catalog, "GLP-1" names a synthetic peptide within the incretin family, studied for its interaction with the glucagon-like peptide-1 receptor (GLP1R). The native ligand this class derives from is a short peptide cleaved from proglucagon (the GCG gene product) in the gut. Because suppliers differ on the exact analog and chain length they supply, the reliable identity anchor is the receptor and its native ligand rather than a single quoted mass. The GLP-1 receptor is a class B G-protein-coupled receptor, and that receptor mechanism is what the research literature characterizes.

What does the research literature study?#

The physiology of GLP-1 signaling has been mapped in detail, and the peptide is a standard reference point for how a class B GPCR converts ligand binding into an intracellular cAMP signal. Structural work resolved the GLP-1 receptor bound to a peptide agonist, which showed how the receptor's large extracellular domain captures the peptide before the transmembrane core engages. A long-form pharmacology review then placed GLP1R within the broader class B receptor family. Because the same receptor can favor different downstream pathways depending on how it is engaged, biased agonism at GLP1R is an active line of receptor-signaling research. All of this is preclinical pharmacology in cells and isolated tissue and does not describe effects in people.

Where GLP-1 sits among the metabolic peptides#

GLP-1 acts at a single incretin receptor. The triple agonist GLP-3 engages the GLP-1, GIP, and glucagon receptors together, which is studied precisely against a single-receptor baseline like GLP-1. The amylin analog Cagrilintide acts on a separate receptor system entirely. The three appear in overlapping energy-balance research yet reach it by different receptors, a distinction the metabolic peptides overview maps in full.

Handling and storage#

GLP-1 ships as a lyophilized powder for reconstitution. Storage follows the standard catalog practice: the reconstitution primer covers solvent choice and aggregation, and the cold-chain article covers how stability changes once the powder is in solution.

Sources and further reading#

• GLP-1 receptor (GLP1R), UniProt P43220: canonical annotation for the class B GPCR that GLP-1 binds.
• Proglucagon (GCG), UniProt P01275: the precursor from which the native GLP-1 ligand is cleaved.
• The physiology of glucagon-like peptide 1, Physiol Rev 2007 (PMID 17928588): foundational review of GLP-1 receptor biology and signaling.
• Crystal structure of the GLP-1 receptor bound to a peptide agonist, Nature 2017 (PMID 28562585): structural account of peptide capture by the receptor.
• GLP-1 and its class B GPCRs: a long march to therapeutic successes, Pharmacol Rev 2016 (PMID 27630114): pharmacology of GLP1R within the class B receptor family.
• The therapeutic potential of GLP-1 receptor biased agonism, Br J Pharmacol 2022 (PMID 33880754): biased-signaling research at the GLP-1 receptor.